All Stories

SCIENCE & INNOVATION 09.17.2024

ESMO 2024: Targeting the Root Cause of Cancers

Three ways Amgen is leveraging emerging biomarkers and new modalities in oncology.

Read more

All Stories <i class="fa fa-angle-down"></i><i class="fa fa-angle-up"></i>

SCIENCE & INNOVATION 09.17.2024
ESMO 2024: Targeting the Root Cause of Cancers
SCIENCE & INNOVATION 06.20.2024
Amgen Continues to Propel BiTE® Technology Innovation
SCIENCE & INNOVATION 11.28.2023
Any Target, Every Time
r00.01_MurielleVeniantEllison_360x244
SCIENCE & INNOVATION 11.23.2021
In a First for Industry, Murielle Véniant-Ellison Honored With 2022 Havel Lectureship
website banner 360x244
SCIENCE & INNOVATION 10.21.2021
Introducing Undruggable, a New Serial Podcast from Amgen R&D Exploring how Multispecifics can Usher in the Next Wave of Drug Discovery
best_of_cell-tile
SCIENCE & INNOVATION 01.07.2021
Amgen Paper Selected for Best of Cell, a Rare Honor for Industry Scientists
science-cartoon-tile-desktop
SCIENCE & INNOVATION 10.06.2020
Undruggable Targets Meet Their Match in New Amgen Science Cartoon
ray-tile-desktop
SCIENCE & INNOVATION 09.28.2020
Amgen Hosts Live Fireside Chat on New Age of Multispecific Medicines
SCIENCE & INNOVATION 08.21.2020
A Story of Scientific Serendipity
SCIENCE & INNOVATION 12.19.2019
Three Ways Biotech Is Changing How We Treat Cancer